U.S. markets open in 6 hours 6 minutes
  • S&P Futures

    3,856.75
    +8.50 (+0.22%)
     
  • Dow Futures

    31,091.00
    +78.00 (+0.25%)
     
  • Nasdaq Futures

    11,908.75
    +28.50 (+0.24%)
     
  • Russell 2000 Futures

    1,734.30
    +5.70 (+0.33%)
     
  • Crude Oil

    98.99
    +0.46 (+0.47%)
     
  • Gold

    1,741.60
    +5.10 (+0.29%)
     
  • Silver

    19.25
    +0.10 (+0.50%)
     
  • EUR/USD

    1.0196
    +0.0011 (+0.11%)
     
  • 10-Yr Bond

    2.9130
    0.0000 (0.00%)
     
  • Vix

    26.73
    -0.81 (-2.94%)
     
  • GBP/USD

    1.1956
    +0.0034 (+0.29%)
     
  • USD/JPY

    135.8420
    -0.0730 (-0.05%)
     
  • BTC-USD

    20,333.45
    +200.25 (+0.99%)
     
  • CMC Crypto 200

    442.17
    +6.64 (+1.53%)
     
  • FTSE 100

    7,176.83
    +69.06 (+0.97%)
     
  • Nikkei 225

    26,490.53
    +382.88 (+1.47%)
     

Alkermes to Participate in the Goldman Sachs Healthcare Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

DUBLIN, June 8, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the Goldman Sachs 43rd Annual Global Healthcare Conference on Wednesday, June 15, 2022 at 2:40 p.m. PT (5:40 p.m. ET/10:40 p.m. BST). The live webcast may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

About Alkermes plc

Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Contact:
Alex Braun
Investor Relations
+1 781 296 8493

 

Alkermes plc Logo (PRNewsfoto/Alkermes plc)
Alkermes plc Logo (PRNewsfoto/Alkermes plc)

 

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/alkermes-to-participate-in-the-goldman-sachs-healthcare-conference-301563683.html

SOURCE Alkermes plc